Clinical Trial Update: Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil) [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated coadministration of GSK1278863A with a high-fat meal or with Gemfibrozil (a CYP2C8 inhibitor) in anaemia; the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaemia

Drugs mentioned

• GSK1278863A (GSK1278863A)
• Gemfibrozil (Gemfibrozil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED